GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,777.50p
   
  • Change Today:
    -10.50p
  • 52 Week High: 1,789.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,060.14m
  • Volume: 565,037
  • Market Cap: £72,169m
  • RiskGrade: 129
  • Beta: 0.93

Latest ShareCast News

GSK posts better-than-expected Q3, upgrades guidance

By Josh White

Date: Wednesday 29 Oct 2025

(Sharecast News) - GSK raised its full-year guidance on Wednesday, after delivering stronger-than-expected third-quarter results, driven by robust growth in specialty medicines and steady contributions from its vaccines and general medicines divisions.

GSK ShareCast News

GSK lung cancer treatment gets EU orphan drug st... 28-Oct-2025 ShareCast
GSK shares lift on £268m prostate cancer deal 27-Oct-2025 ShareCast
GSK's Blenrep receives US FDA approval 24-Oct-2025 ShareCast
GSK advances low-carbon inhaler, halts latozinem... 22-Oct-2025 ShareCast
GSK reports positive trial data for oral cUTI tr... 21-Oct-2025 ShareCast

GSK Regulatory News

Transaction in Own Shares 06-Nov-2025 07:00 RNS
Transaction in Own Shares 05-Nov-2025 07:00 RNS
Transaction in Own Shares 04-Nov-2025 07:00 RNS
Total Voting Rights 03-Nov-2025 15:00 RNS
Transaction in Own Shares 03-Nov-2025 07:00 RNS

GSK Newspaper Links

GSK’s Emma Walmsley bows out on a high 30-Oct-2025 Times
GSK’s Emma Walmsley bows out with guidance upgrade 29-Oct-2025 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,777.50p
Change Today -10.50p
% Change -0.59 %
52 Week High 1,789.50
52 Week Low 1,264.00
Volume 565,037
Shares Issued 4,060.14m
Market Cap £72,169m
Beta 0.93
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 13
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 13-Nov-25 14-Aug-25
Paid 08-Jan-26 09-Oct-25
Amount 16.00p 16.00p

Trades for 06-Nov-2025

Time Volume / Share Price
09:32 2 @ 1,777.00p
09:32 300 @ 1,777.59p
09:32 1 @ 1,778.50p
09:32 578 @ 1,777.50p
09:32 339 @ 1,778.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page